Kota Ishizawa

2.4k total citations
46 papers, 1.5k citations indexed

About

Kota Ishizawa is a scholar working on Pulmonary and Respiratory Medicine, Molecular Biology and Oncology. According to data from OpenAlex, Kota Ishizawa has authored 46 papers receiving a total of 1.5k indexed citations (citations by other indexed papers that have themselves been cited), including 16 papers in Pulmonary and Respiratory Medicine, 10 papers in Molecular Biology and 10 papers in Oncology. Recurrent topics in Kota Ishizawa's work include Chronic Kidney Disease and Diabetes (4 papers), Lung Cancer Treatments and Mutations (4 papers) and Neonatal Respiratory Health Research (4 papers). Kota Ishizawa is often cited by papers focused on Chronic Kidney Disease and Diabetes (4 papers), Lung Cancer Treatments and Mutations (4 papers) and Neonatal Respiratory Health Research (4 papers). Kota Ishizawa collaborates with scholars based in Japan, United States and United Kingdom. Kota Ishizawa's co-authors include Hiroshi Kubo, Mitsuhiro Yamada, Seiichi Kobayashi, Takashi Suzuki, Hidetada Sasaki, Muneo Numasaki, Shinsaku Ueda, Mutsuo Yamaya, Mei He and Yasuhiko Yamamoto and has published in prestigious journals such as Nature Communications, Journal of Clinical Oncology and SHILAP Revista de lepidopterología.

In The Last Decade

Kota Ishizawa

41 papers receiving 1.4k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Kota Ishizawa Japan 16 666 512 295 281 231 46 1.5k
Naoya Fujino Japan 23 721 1.1× 559 1.1× 240 0.8× 88 0.3× 95 0.4× 58 1.5k
Laura Necula Romania 18 285 0.4× 563 1.1× 226 0.8× 144 0.5× 293 1.3× 34 1.5k
Edda Spiekerkoetter United States 28 2.2k 3.3× 660 1.3× 455 1.5× 389 1.4× 206 0.9× 75 2.9k
Ragini Vittal United States 19 904 1.4× 597 1.2× 261 0.9× 61 0.2× 180 0.8× 33 1.9k
Xing Jin China 16 171 0.3× 278 0.5× 256 0.9× 87 0.3× 138 0.6× 71 937
Takafumi Toyohara Japan 20 233 0.3× 733 1.4× 310 1.1× 62 0.2× 248 1.1× 42 1.5k
Stefan Gauer Germany 22 122 0.2× 462 0.9× 374 1.3× 238 0.8× 207 0.9× 42 1.5k
Sunder Sims‐Lucas United States 27 521 0.8× 1.2k 2.4× 429 1.5× 76 0.3× 73 0.3× 77 2.0k
Valery Leytin Canada 21 242 0.4× 436 0.9× 217 0.7× 111 0.4× 98 0.4× 49 1.8k

Countries citing papers authored by Kota Ishizawa

Since Specialization
Citations

This map shows the geographic impact of Kota Ishizawa's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Kota Ishizawa with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Kota Ishizawa more than expected).

Fields of papers citing papers by Kota Ishizawa

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Kota Ishizawa. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Kota Ishizawa. The network helps show where Kota Ishizawa may publish in the future.

Co-authorship network of co-authors of Kota Ishizawa

This figure shows the co-authorship network connecting the top 25 collaborators of Kota Ishizawa. A scholar is included among the top collaborators of Kota Ishizawa based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Kota Ishizawa. Kota Ishizawa is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Yamamoto, Nobuyuki, Kota Ishizawa, Masakazu Umemoto, et al.. (2025). Evaluation of Minimal Residual Disease in Patients with Neuroblastoma. Molecular Diagnosis & Therapy. 29(4). 443–452.
2.
Ono, Rie, Shin Takayama, Natsumi Saito, et al.. (2024). A Case Series of Post-COVID Conditions with Fatigability Treated with Saikokeishito. An Official Journal of the Japan Primary Care Association. 47(2). 49–55. 1 indexed citations
3.
Abe, Michiaki, Takuhiro Yamaguchi, S. Koshiba, et al.. (2024). Oral alkalinizing supplementation suppressed intrarenal reactive oxidative stress in mild-stage chronic kidney disease: a randomized cohort study. Clinical and Experimental Nephrology. 28(11). 1134–1154.
4.
Akaishi, Tetsuya, Shigeki Kushimoto, Yukio Katori, et al.. (2022). COVID-19-Related Symptoms during the SARS-CoV-2 Omicron (B.1.1.529) Variant Surge in Japan. The Tohoku Journal of Experimental Medicine. 258(2). 103–110. 10 indexed citations
5.
Odintsov, Igor, Kota Ishizawa, Isao Miyazaki, et al.. (2022). Comparison of TAS0953/HM06 and selpercatinib in RET fusion-driven preclinical disease models of intracranial metastases.. Journal of Clinical Oncology. 40(16_suppl). 2024–2024. 8 indexed citations
6.
Odintsov, Igor, Kota Ishizawa, Lukas Delasos, et al.. (2021). Abstract P233: TAS0953/HM06 is effective in preclinical models of diverse tumor types driven by RET alterations. Molecular Cancer Therapeutics. 20(12_Supplement). P233–P233. 5 indexed citations
7.
Okuda, Hiroshi, Takayuki Okamoto, Michiaki Abe, et al.. (2020). Genome-wide association study identifies new loci for albuminuria in the Japanese population. Clinical and Experimental Nephrology. 24(8). 1–9. 7 indexed citations
8.
Saiki, Yuriko, et al.. (2020). Genetic and epigenetic aberrations of ABCB1 synergistically boost the acquisition of taxane resistance in esophageal squamous cancer cells. Biochemical and Biophysical Research Communications. 526(3). 586–591. 11 indexed citations
9.
Shimizu, Masayuki, Shin Takayama, Akiko Kikuchi, et al.. (2020). Integrative therapy for advanced pancreatic cancer using Kampo and western medicine: A case report. EXPLORE. 17(3). 255–258. 6 indexed citations
10.
Akaishi, Tetsuya, Hideyasu Kiyomoto, Michiaki Abe, et al.. (2019). A 29-year-old Woman with Recurrent Pregnancy-induced Hypertension Based on Vascular Compression of the Medulla Oblongata. Internal Medicine. 58(15). 2257–2261. 3 indexed citations
11.
Akaishi, Tetsuya, Michiaki Abe, Kota Ishizawa, et al.. (2019). High glucose level and angiotensin II type 1 receptor stimulation synergistically amplify oxidative stress in renal mesangial cells. Scientific Reports. 9(1). 5214–5214. 9 indexed citations
12.
Shiga, Kiyoto, Sho Fujiwara, Kota Ishizawa, et al.. (2018). A Novel <i>SDHB </i>IVS2-2A>C Mutation Is Responsible for Hereditary Pheochromocytoma/Paraganglioma Syndrome. The Tohoku Journal of Experimental Medicine. 245(2). 99–105. 3 indexed citations
13.
Yamada, Mitsuhiro, Hiroshi Kubo, Seiichi Kobayashi, et al.. (2011). The increase in surface CXCR4 expression on lung extravascular neutrophils and its effects on neutrophils during endotoxin-induced lung injury. Cellular and Molecular Immunology. 8(4). 305–314. 73 indexed citations
14.
He, Mei, Hiroshi Kubo, Kota Ishizawa, et al.. (2007). The role of the receptor for advanced glycation end-products in lung fibrosis. American Journal of Physiology-Lung Cellular and Molecular Physiology. 293(6). L1427–L1436. 143 indexed citations
15.
Gu, Zhaodi, et al.. (2007). The FBXW7 β-form is suppressed in human glioma cells. Biochemical and Biophysical Research Communications. 354(4). 992–998. 27 indexed citations
16.
Kobayashi, Seiichi, Hiroshi Kubo, Takashi Suzuki, et al.. (2006). Endogenous Secretory Receptor for Advanced Glycation End Products in Non–Small Cell Lung Carcinoma. American Journal of Respiratory and Critical Care Medicine. 175(2). 184–189. 19 indexed citations
17.
Yamada, Mitsuhiro, Hiroshi Kubo, Seiichi Kobayashi, et al.. (2004). Bone Marrow-Derived Progenitor Cells Are Important for Lung Repair after Lipopolysaccharide-Induced Lung Injury. The Journal of Immunology. 172(2). 1266–1272. 267 indexed citations
18.
Ishizawa, Kota, Hiroshi Kubo, Mitsuhiro Yamada, et al.. (2004). Hepatocyte growth factor induces angiogenesis in injured lungs through mobilizing endothelial progenitor cells. Biochemical and Biophysical Research Communications. 324(1). 276–280. 107 indexed citations
19.
Ishizawa, Kota, Hiroshi Kubo, Mitsuhiro Yamada, et al.. (2003). Bone marrow‐derived cells contribute to lung regeneration after elastase‐induced pulmonary emphysema. FEBS Letters. 556(1-3). 249–252. 183 indexed citations
20.
Chang‐Liu, Chin‐Mei, et al.. (1997). The effects of vinblastine on the expression of human immunodeficiency virus type 1 long terminal repeat. Leukemia Research. 21(5). 459–464. 3 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Naoya Fujino Breakdown of academic impact, for papers by Laura Necula Breakdown of academic impact, for papers by Edda Spiekerkoetter Breakdown of academic impact, for papers by Ragini Vittal Breakdown of academic impact, for papers by Xing Jin Breakdown of academic impact, for papers by Takafumi Toyohara Breakdown of academic impact, for papers by Stefan Gauer Breakdown of academic impact, for papers by Sunder Sims‐Lucas Breakdown of academic impact, for papers by Valery Leytin
Rankless by CCL
2026